Marion McCourt - 07 May 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Commercial
Signature
/s/**Marion McCourt
Issuer symbol
REGN
Transactions as of
07 May 2021
Net transactions value
-$152,700
Form type
4
Filing time
10 May 2021, 16:02:18 UTC
Next filing
08 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $342,930 +1,000 +5.9% $342.93 18,038 07 May 2021 Direct
transaction REGN Common Stock Sale $495,630 -1,000 -5.5% $495.63 17,038 07 May 2021 Direct F1
holding REGN Common Stock 108 07 May 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,000 -5.6% $0.000000 17,000 07 May 2021 Common Stock 1,000 $342.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 1,000 shares of Company stock on May 7, 2021 at prices ranging from $495.47 to $495.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2021 at each separate price.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.